Investors – A privately held company, Magellan Biosciences is majority-owned by Ampersand Ventures. Other investors include Abingworth Management, Boston Community Venture Fund, Hambrecht & Quist Capital Management, KBL Healthcare Ventures, New England Partners Capital LP, and Nexus Medical Partners II SICAR. As such, we do not release our company financials. Our goal is to deliver double-digit revenue growth, balanced between internal growth and acquisitions.